news
Cata-Kor Testing Finds Commercial Berberine Supplements Fail Label Claims
Independent testing by Cata-Kor revealed that multiple retail berberine supplements contain far less active compound than printed on their fact panels. The extract surged as a metabolic aid, but loose manufacturing oversight leaves buyers with sub-therapeutic doses. Anyone taking 500 milligrams for glucose control may actually be swallowing a fraction of that.
Independent testing by Cata-Kor revealed that multiple retail berberine supplements contain far less active compound than printed on their fact panels. The extract surged as a metabolic aid, but loose manufacturing oversight leaves buyers with sub-therapeutic doses. Anyone taking 500 milligrams for glucose control may actually be swallowing a fraction of that.
The architecture take
I bought my first bottle of berberine two years ago when social media decided it was cheap metabolic magic, and half my friends started taking 500 milligrams before dinner. Berberine actually has solid clinical data behind it: it activates AMPK, curbs post-meal blood sugar spikes, and nudges gut bacteria in ways that support insulin sensitivity. But testing from Cata-Kor shows what supplement insiders already know. When an ingredient surges in popularity, cheap white-label suppliers flood online storefronts with capsules carrying a fraction of the stated dose. If a capsule promises 500 milligrams and delivers 150, your liver and gut don't get the concentration needed to shift glucose transport. Third-party certification is boring. It matters far more than an aesthetic bottle, though. Watch for retailers to quietly purge substandard batches over the next six months as independent lab audits get louder. Until then, stick to verified certificates of analysis.